NS
CRBP icon

NBC Securities’s Corbus Pharmaceuticals CRBP Stock Holding History

NBC Securities’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$309 Hold
33
– – ﹤0.01% 2492
2025
Q4 		$268 Hold
33
– – ﹤0.01% 2694
2025
Q3 		$417 Buy
+33
New +$314 ﹤0.01% 2662
2024
Q3 		– Sell
-33
Closed -$1K – 2132
2024
Q2 		$1K Hold
33
– – ﹤0.01% 2031
2024
Q1 		$1K Buy
+33
New +$814 ﹤0.01% 2053
2023
Q4 		– Sell
-33
Closed – – 2130
2023
Q3 		$0 Buy
+33
New +$228 ﹤0.01% 2121

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NBC Securities's CRBP Position: Q1 2026 in Review

NBC Securities held its Corbus Pharmaceuticals (CRBP) position steady in Q1 2026 at 33 shares worth $309. The position accounts for ﹤0.01% of the portfolio, ranked #2492.

NBC Securities first reported a position in CRBP in Q3 2023 and has held it in 6 quarters since. The position peaked at $1K in Q2 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • NBC Securities held 33 shares of Corbus Pharmaceuticals worth $309 as of Q1 2026.
  • NBC Securities left its Corbus Pharmaceuticals share count unchanged in Q1 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of NBC Securities's portfolio in Q1 2026, its #2492 holding.
  • NBC Securities first reported a position in Corbus Pharmaceuticals in Q3 2023 and has held it in 6 quarters since.
  • NBC Securities's Corbus Pharmaceuticals position peaked at $1K in Q2 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on NBC Securities's 13F filing for Q1 2026, filed 14 Apr 2026.